Human clinical evidence for TB-500 (a synthetic form of thymosin beta-4) is limited because most peer-reviewed studies involve the native peptide thymosin beta-4 in wound-healing settings rather than TB-500 specifically, but research does show its regenerative and anti-inflammatory effects in humans
DPP-4-resistant peptide mimics of natural GLP-1 have been pioneered to maintain and boost the biological response of GLP-1R activation
This wasnt a separate, head-to-head trial focused only on cagrilintide, but rather a closer look at specific results from an existing study
Ozempic face was coined by a dermatologist, Paul Jarrold Frank, to describe the facial aging that many of his patients who receive GLP-1RA suffer from
It adds that early improvement more likely reflects reduced inflammation than any structural change in cartilage, which develops far more slowly
What you can explore: Is your diet rich in antioxidants (berries, colourful vegetables)